Juchum M[au] - Search Results

Year	Number of Results
1950	1
2008	1
2014	1
2015	1
2016	2
2017	3
2020	3
2021	3
2022	0

1

Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4.

Kircher T, Pantsar T, Oder A, Peter von Kries J, Juchum M, Pfaffenrot B, Kloevekorn P, Albrecht W, Selig R, Laufer S. Kircher T, et al. Among authors: juchum m. Eur J Med Chem. 2021 Jan 1;209:112901. doi: 10.1016/j.ejmech.2020.112901. Epub 2020 Oct 4. Eur J Med Chem. 2021. PMID: 33092905

2

From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4).

Klövekorn P, Pfaffenrot B, Juchum M, Selig R, Albrecht W, Zender L, Laufer SA. Klövekorn P, et al. Among authors: juchum m. Eur J Med Chem. 2021 Jan 15;210:112963. doi: 10.1016/j.ejmech.2020.112963. Epub 2020 Oct 24. Eur J Med Chem. 2021. PMID: 33199152

3

Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors.

Juchum M, Günther M, Laufer SA. Juchum M, et al. Drug Resist Updat. 2015 May;20:12-28. doi: 10.1016/j.drup.2015.05.002. Epub 2015 May 12. Drug Resist Updat. 2015. PMID: 26021435 Review.

4

Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration.

Pfaffenrot B, Klövekorn P, Juchum M, Selig R, Albrecht W, Zender L, Laufer SA. Pfaffenrot B, et al. Among authors: juchum m. Eur J Med Chem. 2021 Jun 5;218:113371. doi: 10.1016/j.ejmech.2021.113371. Epub 2021 Mar 17. Eur J Med Chem. 2021. PMID: 33794385

5

Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012-2018.

Engler C, Leo M, Pfeifer B, Juchum M, Chen-Koenig D, Poelzl K, Schoenherr H, Vill D, Oberdanner J, Eisendle E, Middeldorf K, Heindl B, Gaenzer H, Bode G, Kirchmeyr K, Ladner G, Rieger L, Koellensperger U, Schwaiger A, Stoeckl F, Zangerl G, Lechleitner M, Delmarko I, Oberaigner W, Rissbacher C, Tilg H, Ebenbichler C. Engler C, et al. Among authors: juchum m. BMJ Open Diabetes Res Care. 2020 Sep;8(1):e001279. doi: 10.1136/bmjdrc-2020-001279. BMJ Open Diabetes Res Care. 2020. PMID: 32873600 Free PMC article.

6

Lung Cancer: EGFR Inhibitors with Low Nanomolar Activity against a Therapy-Resistant L858R/T790M/C797S Mutant.

Günther M, Juchum M, Kelter G, Fiebig H, Laufer S. Günther M, et al. Among authors: juchum m. Angew Chem Int Ed Engl. 2016 Aug 26;55(36):10890-4. doi: 10.1002/anie.201603736. Epub 2016 Jul 28. Angew Chem Int Ed Engl. 2016. PMID: 27466205

7

Prescription of oral antidiabetic drugs in Tyrol - Data from the Tyrol diabetes registry 2012-2015.

Lunger L, Melmer A, Oberaigner W, Leo M, Juchum M, Pölzl K, Gänzer J, Innerebner M, Eisendle E, Beck G, Kathrein H, Heindl B, Schönherr HR, Lechleitner M, Tilg H, Ebenbichler C. Lunger L, et al. Among authors: juchum m. Wien Klin Wochenschr. 2017 Jan;129(1-2):46-51. doi: 10.1007/s00508-016-1135-1. Epub 2016 Dec 1. Wien Klin Wochenschr. 2017. PMID: 27909794 Free PMC article.

8

Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site.

Günther M, Lategahn J, Juchum M, Döring E, Keul M, Engel J, Tumbrink HL, Rauh D, Laufer S. Günther M, et al. Among authors: juchum m. J Med Chem. 2017 Jul 13;60(13):5613-5637. doi: 10.1021/acs.jmedchem.7b00316. Epub 2017 Jun 21. J Med Chem. 2017. PMID: 28603991

9

Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping.

Juchum M, Günther M, Döring E, Sievers-Engler A, Lämmerhofer M, Laufer S. Juchum M, et al. J Med Chem. 2017 Jun 8;60(11):4636-4656. doi: 10.1021/acs.jmedchem.7b00178. Epub 2017 May 23. J Med Chem. 2017. PMID: 28482151

10

Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria.

Oberaigner W, Ebenbichler C, Oberaigner K, Juchum M, Schönherr HR, Lechleitner M. Oberaigner W, et al. Among authors: juchum m. BMC Public Health. 2014 Oct 10;14:1058. doi: 10.1186/1471-2458-14-1058. BMC Public Health. 2014. PMID: 25300498 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results